Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial
Aim To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A secondary aim was to examine a possible added effect of chlorhexidine to these therapies. Methods One hundred and eighteen subjects recei...
Saved in:
Published in | Journal of clinical periodontology Vol. 39; no. 12; pp. 1149 - 1158 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Blackwell Publishing Ltd
01.12.2012
Blackwell |
Subjects | |
Online Access | Get full text |
ISSN | 0303-6979 1600-051X 1600-051X |
DOI | 10.1111/jcpe.12004 |
Cover
Abstract | Aim
To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A secondary aim was to examine a possible added effect of chlorhexidine to these therapies.
Methods
One hundred and eighteen subjects received scaling and root planing (SRP) only or with MTZ [400 mg/thrice a day (TID)] or MTZ+AMX (500 mg/TID) for 14 days. Half of the subjects in each group rinsed with 0.12% chlorhexidine twice a day (BID) for 2 months. Subjects were clinically monitored at baseline, 3, 6 and 12‐months post‐therapy.
Results
The two antibiotic groups showed lower mean number of sites with probing depth (PD) ≥5 mm and fewer subjects exhibiting ≥9 of these sites at 1‐year post‐treatment. Logistic regression analysis showed that antibiotics were the only significant predictors of subjects presenting ≤4 sites with PD ≥5 mm at 1 year (MTZ+AMX: OR, 13.33; 95%CI, 3.75‐47.39/p = 0.0000; MTZ: OR, 7.26; 95%CI, 2.26‐23.30/p = 0.0004). The frequency of adverse events did not differ between the two antibiotic treatments (p > 0.05). The chlorhexidine subgroups showed a trend (p > 0.05) to present fewer residual sites ≥5 mm compared with the placebo subgroups at 1 year.
Conclusion
Treatment of generalized ChP is significantly improved by the adjunctive use of MTZ+AMX and MTZ.
View the pubcast on this paper at http://scivee-1.sdsc.edu/node/55261 |
---|---|
AbstractList | Aim To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A secondary aim was to examine a possible added effect of chlorhexidine to these therapies. Methods One hundred and eighteen subjects received scaling and root planing (SRP) only or with MTZ [400 mg/thrice a day (TID)] or MTZ+AMX (500 mg/TID) for 14 days. Half of the subjects in each group rinsed with 0.12% chlorhexidine twice a day (BID) for 2 months. Subjects were clinically monitored at baseline, 3, 6 and 12-months post-therapy. Results The two antibiotic groups showed lower mean number of sites with probing depth (PD) ≥5 mm and fewer subjects exhibiting ≥9 of these sites at 1-year post-treatment. Logistic regression analysis showed that antibiotics were the only significant predictors of subjects presenting ≤4 sites with PD ≥5 mm at 1 year (MTZ+AMX:OR, 13.33; 95%CI, 3.75-47.39/p = 0.0000; MTZ:OR, 7.26; 95%CI, 2.26-23.30/p = 0.0004). The frequency of adverse events did not differ between the two antibiotic treatments (p > 0.05). The chlorhexidine subgroups showed a trend (p > 0.05) to present fewer residual sites ≥5 mm compared with the placebo subgroups at 1 year. Conclusion Treatment of generalized ChP is significantly improved by the adjunctive use of MTZ+AMX and MTZ. View the pubcast on this paper at http://scivee-1.sdsc.edu/node/55261 [PUBLICATION ABSTRACT] To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A secondary aim was to examine a possible added effect of chlorhexidine to these therapies. One hundred and eighteen subjects received scaling and root planing (SRP) only or with MTZ [400 mg/thrice a day (TID)] or MTZ+AMX (500 mg/TID) for 14 days. Half of the subjects in each group rinsed with 0.12% chlorhexidine twice a day (BID) for 2 months. Subjects were clinically monitored at baseline, 3, 6 and 12-months post-therapy. The two antibiotic groups showed lower mean number of sites with probing depth (PD) ≥5 mm and fewer subjects exhibiting ≥9 of these sites at 1-year post-treatment. Logistic regression analysis showed that antibiotics were the only significant predictors of subjects presenting ≤4 sites with PD ≥5 mm at 1 year (MTZ+AMX: OR, 13.33; 95%CI, 3.75-47.39/p = 0.0000; MTZ: OR, 7.26; 95%CI, 2.26-23.30/p = 0.0004). The frequency of adverse events did not differ between the two antibiotic treatments (p > 0.05). The chlorhexidine subgroups showed a trend (p > 0.05) to present fewer residual sites ≥5 mm compared with the placebo subgroups at 1 year. Treatment of generalized ChP is significantly improved by the adjunctive use of MTZ+AMX and MTZ. View the pubcast on this paper at http://scivee-1.sdsc.edu/node/55261 Aim To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A secondary aim was to examine a possible added effect of chlorhexidine to these therapies. Methods One hundred and eighteen subjects received scaling and root planing (SRP) only or with MTZ [400 mg/thrice a day (TID)] or MTZ+AMX (500 mg/TID) for 14 days. Half of the subjects in each group rinsed with 0.12% chlorhexidine twice a day (BID) for 2 months. Subjects were clinically monitored at baseline, 3, 6 and 12‐months post‐therapy. Results The two antibiotic groups showed lower mean number of sites with probing depth (PD) ≥5 mm and fewer subjects exhibiting ≥9 of these sites at 1‐year post‐treatment. Logistic regression analysis showed that antibiotics were the only significant predictors of subjects presenting ≤4 sites with PD ≥5 mm at 1 year (MTZ+AMX: OR, 13.33; 95%CI, 3.75‐47.39/p = 0.0000; MTZ: OR, 7.26; 95%CI, 2.26‐23.30/p = 0.0004). The frequency of adverse events did not differ between the two antibiotic treatments (p > 0.05). The chlorhexidine subgroups showed a trend (p > 0.05) to present fewer residual sites ≥5 mm compared with the placebo subgroups at 1 year. Conclusion Treatment of generalized ChP is significantly improved by the adjunctive use of MTZ+AMX and MTZ. View the pubcast on this paper at http://scivee-1.sdsc.edu/node/55261 To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A secondary aim was to examine a possible added effect of chlorhexidine to these therapies.AIMTo evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A secondary aim was to examine a possible added effect of chlorhexidine to these therapies.One hundred and eighteen subjects received scaling and root planing (SRP) only or with MTZ [400 mg/thrice a day (TID)] or MTZ+AMX (500 mg/TID) for 14 days. Half of the subjects in each group rinsed with 0.12% chlorhexidine twice a day (BID) for 2 months. Subjects were clinically monitored at baseline, 3, 6 and 12-months post-therapy.METHODSOne hundred and eighteen subjects received scaling and root planing (SRP) only or with MTZ [400 mg/thrice a day (TID)] or MTZ+AMX (500 mg/TID) for 14 days. Half of the subjects in each group rinsed with 0.12% chlorhexidine twice a day (BID) for 2 months. Subjects were clinically monitored at baseline, 3, 6 and 12-months post-therapy.The two antibiotic groups showed lower mean number of sites with probing depth (PD) ≥5 mm and fewer subjects exhibiting ≥9 of these sites at 1-year post-treatment. Logistic regression analysis showed that antibiotics were the only significant predictors of subjects presenting ≤4 sites with PD ≥5 mm at 1 year (MTZ+AMX: OR, 13.33; 95%CI, 3.75-47.39/p = 0.0000; MTZ: OR, 7.26; 95%CI, 2.26-23.30/p = 0.0004). The frequency of adverse events did not differ between the two antibiotic treatments (p > 0.05). The chlorhexidine subgroups showed a trend (p > 0.05) to present fewer residual sites ≥5 mm compared with the placebo subgroups at 1 year.RESULTSThe two antibiotic groups showed lower mean number of sites with probing depth (PD) ≥5 mm and fewer subjects exhibiting ≥9 of these sites at 1-year post-treatment. Logistic regression analysis showed that antibiotics were the only significant predictors of subjects presenting ≤4 sites with PD ≥5 mm at 1 year (MTZ+AMX: OR, 13.33; 95%CI, 3.75-47.39/p = 0.0000; MTZ: OR, 7.26; 95%CI, 2.26-23.30/p = 0.0004). The frequency of adverse events did not differ between the two antibiotic treatments (p > 0.05). The chlorhexidine subgroups showed a trend (p > 0.05) to present fewer residual sites ≥5 mm compared with the placebo subgroups at 1 year.Treatment of generalized ChP is significantly improved by the adjunctive use of MTZ+AMX and MTZ.CONCLUSIONTreatment of generalized ChP is significantly improved by the adjunctive use of MTZ+AMX and MTZ. |
Author | Soares, Geisla Mary Silva Faveri, Marcelo Socransky, Sigmund S. Feres, Magda Silva, Maike Paulino Teles, Ricardo Mendes, Juliana Alethusa Velloso Figueiredo, Luciene Cristina |
Author_xml | – sequence: 1 givenname: Magda surname: Feres fullname: Feres, Magda email: Address:, mferes@ung.br organization: Department of Periodontology, Dental Research Division, Guarulhos University, São Paulo, Guarulhos, Brazil – sequence: 2 givenname: Geisla Mary Silva surname: Soares fullname: Soares, Geisla Mary Silva organization: Department of Periodontology, Dental Research Division, Guarulhos University, São Paulo, Guarulhos, Brazil – sequence: 3 givenname: Juliana Alethusa Velloso surname: Mendes fullname: Mendes, Juliana Alethusa Velloso organization: Department of Periodontology, Dental Research Division, Guarulhos University, São Paulo, Guarulhos, Brazil – sequence: 4 givenname: Maike Paulino surname: Silva fullname: Silva, Maike Paulino organization: Department of Periodontology, Dental Research Division, Guarulhos University, São Paulo, Guarulhos, Brazil – sequence: 5 givenname: Marcelo surname: Faveri fullname: Faveri, Marcelo organization: Department of Periodontology, Dental Research Division, Guarulhos University, São Paulo, Guarulhos, Brazil – sequence: 6 givenname: Ricardo surname: Teles fullname: Teles, Ricardo organization: The Forsyth Institute, Cambridge, MA, USA – sequence: 7 givenname: Sigmund S. surname: Socransky fullname: Socransky, Sigmund S. organization: The Forsyth Institute, MA, Cambridge, USA – sequence: 8 givenname: Luciene Cristina surname: Figueiredo fullname: Figueiredo, Luciene Cristina organization: Department of Periodontology, Dental Research Division, Guarulhos University, São Paulo, Guarulhos, Brazil |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26674088$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/23016867$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kt9u0zAUxiM0xLrBDQ-ALCEkhMiw48RJuEPVKKAykPgz7qwT-4S5c-NiO9q6h-IZcWkL0oTwjS3r930-5_g7yg4GN2CWPWT0hKX1YqFWeMIKSss72YQJSnNasW8H2YRyynPR1u1hdhTCglJWc87vZYcFp0w0op5kP99j9G4wGm6cRQI2WRPnyZWJFwSW7tooY60ZCAQCejEOKgYSHUkl5GH0340CS6JHiEscInE9URcbP0VW6I3TbogmmvCSAGH5GsET7cbOYt4lU436OVlZUNi5XCXUO2s3dx4G7ZbmBjVRids9YsDez-72YAM-2O3H2ZfXp5-nb_L5h9nb6at5rsq2LPOeApa60EqXgpbYYUELVQnedy2UoHivlWqgVlpV6dx2GqFqO6waXjdViSU_zp5ufVfe_RgxRLk0QaG1MKAbg2SsZo2oalEk9PEtdOFGP6TqJCs5b-pCCJGoRztq7Jao5cqbJfi13P9EAp7sAAip3T6NQJnwlxOiLmnTJI5uOeVdCB57qUyEaDbTA2Mlo3ITCrkJhfwdiiR5dkuyd_0nzLbwlbG4_g8p300_nu41-VZjQsTrPxrwlzJ1Vlfy_Gwmv85n50VDP8kz_gstLNpb |
CitedBy_id | crossref_primary_10_1111_jcpe_12995 crossref_primary_10_1111_jcpe_12994 crossref_primary_10_1002_JPER_22_0301 crossref_primary_10_1111_jcpe_12076 crossref_primary_10_1007_s00784_020_03198_4 crossref_primary_10_1002_JPER_20_0764 crossref_primary_10_1177_0022034516639274 crossref_primary_10_1186_1472_6831_14_159 crossref_primary_10_47820_recima21_v5i11_5843 crossref_primary_10_1002_JPER_22_0657 crossref_primary_10_1016_j_mimet_2015_01_023 crossref_primary_10_1111_adj_12674 crossref_primary_10_1002_14651858_CD012568 crossref_primary_10_1080_08927014_2022_2160242 crossref_primary_10_1016_j_pdpdt_2016_11_016 crossref_primary_10_1007_s00784_020_03292_7 crossref_primary_10_4103_tdj_tdj_38_24 crossref_primary_10_1111_idh_12438 crossref_primary_10_1111_jcpe_13824 crossref_primary_10_1186_s13063_018_2540_8 crossref_primary_10_3390_jcm11113189 crossref_primary_10_1111_jcpe_12217 crossref_primary_10_1902_jop_2013_130278 crossref_primary_10_1111_jcpe_13547 crossref_primary_10_3892_etm_2019_7856 crossref_primary_10_1111_jcpe_12578 crossref_primary_10_1016_j_atherosclerosis_2020_09_019 crossref_primary_10_1111_jcpe_12299 crossref_primary_10_1111_jcpe_13264 crossref_primary_10_3389_fmicb_2023_1122051 crossref_primary_10_1111_jcpe_14082 crossref_primary_10_1002_14651858_CD012568_pub2 crossref_primary_10_1590_1678_7757_2023_ed001 crossref_primary_10_1016_S0022_3913_13_60358_3 crossref_primary_10_1111_jre_13093 crossref_primary_10_1177_2040622320919621 crossref_primary_10_1590_1678_775720140453 crossref_primary_10_1111_jcpe_13704 crossref_primary_10_1111_jphp_12161 crossref_primary_10_1371_journal_pone_0179592 crossref_primary_10_1111_jcpe_14003 crossref_primary_10_1111_jcpe_13551 crossref_primary_10_1111_jre_12821 crossref_primary_10_1111_prd_12358 crossref_primary_10_1111_prd_12075 crossref_primary_10_1186_s13063_021_05246_0 crossref_primary_10_1007_s00784_018_2398_x crossref_primary_10_1902_jop_2014_140478 crossref_primary_10_1111_prd_12235 crossref_primary_10_1016_j_adaj_2017_01_021 crossref_primary_10_1111_jcpe_13838 crossref_primary_10_1902_jop_2013_130142 crossref_primary_10_1016_j_jphotobiol_2017_08_012 crossref_primary_10_1111_jcpe_12559 crossref_primary_10_1111_jre_12252 crossref_primary_10_1590_1807_3107bor_2024_vol38_0121 crossref_primary_10_1007_s00784_015_1499_z crossref_primary_10_1590_1807_3107bor_2021_vol35_0100 crossref_primary_10_5005_jp_journals_10024_3316 crossref_primary_10_1111_jcpe_12155 crossref_primary_10_1111_jcpe_12793 crossref_primary_10_1016_j_pdpdt_2020_101688 crossref_primary_10_1111_prd_12121 crossref_primary_10_1902_jop_2015_140620 crossref_primary_10_1111_idh_12347 crossref_primary_10_1111_cns_70152 crossref_primary_10_1111_odi_14786 crossref_primary_10_1111_adj_12991 crossref_primary_10_15171_jlms_2017_25 crossref_primary_10_4103_jisp_jisp_26_24 crossref_primary_10_1016_j_clinthera_2021_10_016 crossref_primary_10_1111_jcpe_12721 crossref_primary_10_1111_jcpe_13777 crossref_primary_10_1111_jre_12089 crossref_primary_10_3390_antibiotics9020068 crossref_primary_10_1111_jcpe_12441 crossref_primary_10_1111_jcpe_12282 crossref_primary_10_1111_jcpe_13096 crossref_primary_10_1007_s40496_019_00225_6 crossref_primary_10_1007_s00784_018_2392_3 crossref_primary_10_1007_s40496_019_0216_4 crossref_primary_10_1111_prd_12492 crossref_primary_10_3390_genes9060271 crossref_primary_10_3390_antibiotics11010009 crossref_primary_10_1111_jcpe_13464 crossref_primary_10_1002_14651858_CD008676_pub2 crossref_primary_10_1002_JPER_20_0196 crossref_primary_10_1002_JPER_18_0399 crossref_primary_10_3390_antibiotics9100686 crossref_primary_10_1111_adj_12415 crossref_primary_10_1002_cre2_48 crossref_primary_10_1590_1678_7757_2021_0583 crossref_primary_10_1007_s00784_019_02927_8 crossref_primary_10_1111_jre_12221 crossref_primary_10_1128_AAC_04974_14 crossref_primary_10_1186_s12903_015_0123_6 crossref_primary_10_1111_jre_13272 crossref_primary_10_1016_j_identj_2022_11_018 crossref_primary_10_1038_s41598_020_73054_8 crossref_primary_10_17816_KMJ2020_356 crossref_primary_10_1007_s00784_014_1193_6 crossref_primary_10_1039_D0MD00424C crossref_primary_10_1016_j_adaj_2014_12_015 crossref_primary_10_1080_20002297_2023_2213111 crossref_primary_10_1007_s40496_019_00224_7 crossref_primary_10_1111_omi_12459 crossref_primary_10_1007_s41547_019_00063_w crossref_primary_10_1007_s00784_014_1208_3 crossref_primary_10_3390_microorganisms10112172 crossref_primary_10_1016_j_jebdp_2014_04_025 |
Cites_doi | 10.1111/j.1600-051X.2008.01304.x 10.1111/j.1600-0765.1987.tb01574.x 10.1902/jop.1991.62.4.247 10.1902/jop.1984.55.6.325 10.1177/0022034510374737 10.1902/annals.2003.8.1.115 10.1111/j.1600-051X.2004.00605.x 10.1034/j.1600-051x.2001.028007597.x 10.1902/jop.2010.090522 10.1111/j.1600-051X.2006.00905.x 10.1902/jop.2009.080540 10.1111/j.1600-051X.2011.01763.x 10.1111/j.1600-051X.2008.01245.x 10.1034/j.1600-051X.29.s3.8.x 10.1111/j.1875-595X.2003.tb00770.x 10.14219/jada.archive.2003.0225 10.1034/j.1600-051x.2001.028004296.x 10.1111/j.1600-051X.2011.01795.x 10.1111/j.1600-051X.2009.01471.x 10.1111/j.1600-051X.2012.01870.x 10.1111/j.1600-051X.2005.00814.x 10.1111/j.1600-051X.2006.01040.x 10.1111/j.1600-051X.2009.01508.x 10.1902/annals.1999.4.1.1 10.1034/j.1600-051X.2002.290410.x 10.1111/j.1600-051X.1989.tb01626.x 10.1111/j.1600-051X.2011.01766.x 10.1902/jop.2005.76.5.749 10.1111/j.1600-051X.2010.01538.x |
ContentType | Journal Article |
Copyright | 2012 John Wiley & Sons A/S 2014 INIST-CNRS 2012 John Wiley & Sons A/S. Copyright © 2012 John Wiley & Sons A/S |
Copyright_xml | – notice: 2012 John Wiley & Sons A/S – notice: 2014 INIST-CNRS – notice: 2012 John Wiley & Sons A/S. – notice: Copyright © 2012 John Wiley & Sons A/S |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP K9. 7X8 |
DOI | 10.1111/jcpe.12004 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Dentistry |
EISSN | 1600-051X |
EndPage | 1158 |
ExternalDocumentID | 3076290771 23016867 26674088 10_1111_jcpe_12004 JCPE12004 ark_67375_WNG_VLGW280S_N |
Genre | article Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Fundação de Amparo à Pesquisa do Estado de São Paulo |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 1OB 1OC 29K 31~ 33P 34H 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 CWXXS D-E D-F D-I DC6 DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.T H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MJL MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ TEORI UB1 UMD V8K V9Y W8V W99 WBKPD WBNRW WIH WIJ WIK WOHZO WPGGZ WQJ WRC WXSBR XG1 YFH YOC YOJ YUY ZGI ZXP ZZTAW ~IA ~WT AAHQN AAIPD AAMMB AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AEFGJ AEYWJ AFWVQ AGHNM AGQPQ AGXDD AGYGG AIDQK AIDYY ALVPJ AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7QP K9. 7X8 |
ID | FETCH-LOGICAL-c4944-f0ae4d2dcd4604ebe202c563fb9a4ac3fdcc8a7cdc53fd9bdea59be5837854e43 |
IEDL.DBID | DR2 |
ISSN | 0303-6979 1600-051X |
IngestDate | Thu Jul 10 17:06:45 EDT 2025 Fri Jul 25 18:50:44 EDT 2025 Mon Jul 21 06:03:26 EDT 2025 Mon Jul 21 09:10:53 EDT 2025 Thu Apr 24 23:04:06 EDT 2025 Tue Jul 01 01:38:40 EDT 2025 Wed Aug 20 07:26:30 EDT 2025 Wed Oct 30 09:55:03 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Nitro compound Imidazole derivatives scaling and root planing Stomatology β-Lactams chronic periodontitis periodontal treatment Dentistry Penicillin derivatives Tooth root Antiprotozoal agent Antibiotic Antifungal agent Chronic Periodontal disease Treatment Periodontitis Surgery Amoxicillin Parasiticide Clinical trial Metronidazole Antibacterial agent |
Language | English |
License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 2012 John Wiley & Sons A/S. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4944-f0ae4d2dcd4604ebe202c563fb9a4ac3fdcc8a7cdc53fd9bdea59be5837854e43 |
Notes | Fundação de Amparo à Pesquisa do Estado de São Paulo istex:49D1B7CE8A398C48EC7407F9F41AB863536FF47F ArticleID:JCPE12004 Table S1. Demographic characteristics and mean (±SD) full-mouth clinical parameters at baseline in the six experimental groups.Table S2. Mean number and mean percentage (± SD) of sites with PD ≥5 mm (with BOP) at baseline and at follow-up visits. ark:/67375/WNG-VLGW280S-N ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jcpe.12004 |
PMID | 23016867 |
PQID | 1433872666 |
PQPubID | 105484 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1171865762 proquest_journals_1433872666 pubmed_primary_23016867 pascalfrancis_primary_26674088 crossref_citationtrail_10_1111_jcpe_12004 crossref_primary_10_1111_jcpe_12004 wiley_primary_10_1111_jcpe_12004_JCPE12004 istex_primary_ark_67375_WNG_VLGW280S_N |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2012 |
PublicationDateYYYYMMDD | 2012-12-01 |
PublicationDate_xml | – month: 12 year: 2012 text: December 2012 |
PublicationDecade | 2010 |
PublicationPlace | Oxford |
PublicationPlace_xml | – name: Oxford – name: United States – name: Malden |
PublicationTitle | Journal of clinical periodontology |
PublicationTitleAlternate | J Clin Periodontol |
PublicationYear | 2012 |
Publisher | Blackwell Publishing Ltd Blackwell |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Blackwell |
References | Goodson, J. M., Haffajee, A. D., Socransky, S. S., Kent, R., Teles, R., Hasturk, H., Bogren, A., Van Dyke, T., Wennstrom, J. & Lindhe, L. (2012) Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites. Journal of Clinical Periodontology 39, 525-536. Loesche, W. J., Schmidt, E., Smith, B. A., Morrison, E. C., Caffesse, R. & Hujoel, P. P. (1991) Effects of metronidazole on periodontal treatment needs. Journal of Periodontology 62, 247-257. Loesche, W. J., Giordano, J. R., Soehren, S. & Kaciroti, N. (2005) The nonsurgical treatment of patients with periodontal disease: results after 6.4 years. General Dentistry 53, 298-306. Pihlstrom, B. L. & Barnett, M. L. (2010) Design, operation, and interpretation of clinical trials. Journal of Dental Research 89, 759-772. Greenstein, G. (2003) Clinical versus statistical significance as they relate to the efficacy of periodontal therapy. The Journal of the American Dental Association 5, 583-591. Guerrero, A., Griffiths, G. S., Nibali, L., Suvan, J., Moles, D. R., Laurell, L. & Tonetti, M. S. (2005) Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial. Journal of Clinical Periodontololgy 32, 1096-1107. Mestnik, M. J., Feres, M., Figueiredo, L. C., Duarte, P. M., Lira, E. A. G. & Faveri, M. (2010) Short-term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in clinical parameters of subjects with generalized aggressive periodontitis. Journal of Clinical Periodontology 37, 353-365. Armitage, G. C. (1999) Development of a classification system for periodontal disease and conditions. Annals of Periodontology 4, 1-6. Yek, E. C., Cintan, S., Topcuoglu, N., Kulekci, G., Issever, H. & Kantarci, A. (2010) Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis. Journal of Periodontology 81, 964-974. Ehmke, B., Moter, A., Beikler, T., Milian, E. & Flemmig, T.F. (2005) Adjunctive antimicrobial therapy of periodontitis: long term effects on disease progression and oral colonization. Journal of Periodontology 76, 749-759. Aimetti, M., Romano, F., Guzzi, N. & Carnevale, G. (2012) Full-mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo-controlled trial. Journal of Clinical Periodontology 39, 284-294. Herrera, D., Sanz, M., Jepsen, S., Needleman, I. & Roldan, S. (2002) A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. Journal of Clinical Periodontology 29, 136-159. Loesche, W. J., Syed, S. A., Morrison, E. C., Kerry, G. A., Higgins, T. & Stoll, J. (1984) Metronidazole in periodontitis. I. Clinical and bacteriological results after 15 to 30 weeks. Journal of Periodontology 55, 325-335. Carvalho, L. H., D'Avila, G. B., Leao, A., Haffajee, A. D., Socransky, S. S. & Feres, M. (2004) Scaling and root planing, systemic metronidazole and professional plaque removal in the treatment of chronic periodontitis in a Brazilian population. I. clinical results. Journal of Clinical Periodontology 31, 1070-1076. Feres, M., Haffajee, A. D., Allard, K., Som, S. & Socransky, S. S. (2001) Change in subgingival microbial profiles in adult periodontitis subjects receiving either systemically-administered amoxicillin or metronidazole. Journal of Clinical Periodontology 28, 597-609. Rooney, J., Wade, W. G., Sprague, S. V., Newcombe, R. G. & Addy, M. (2002) Adjunctive effects to non-surgical periodontal therapy of systemic metronidazole and amoxicillin alone and combined. A placebo controlled study. Journal of Clinical Periodontology 29, 342-350. Cionca, N., Giannopoulou, C., Ugolotti, G. & Mombelli, A. (2009) Amoxicillin and metronidazole as an adjunct to full-mouth scaling and root planing of chronic periodontitis. Journal of Periodontology 80, 364-371. Feres, M., Gursky, L. C., Faveri, M., Tsuzuki, C.O. & Figueiredo, L. C. (2009) Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology 36, 857-867. Haffajee, A. D., Torresyap, G. & Socransky, S. S. (2007) Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1 year results. Journal of Clinical Periodontololgy 34, 243-253. Loesche, W. J., Schmidt, E., Smith, B. A., Caffessee, R. & Stoll, J. (1987) Metronidazole therapy for periodontitis. Journal of Periodontal Research 22, 224-226. Haffajee, A.D., Arguello, E.I., Ximenez-Fyvie, L.A. & Socransky, S.S. (2003b) Controlling the plaque biofilm. International Dental Journal 53, 191-199. Xajigeorgiou, C., Sakellari, D., Slini, T., Baka, A. & Konstantinidis, A. (2006) Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis. Journal of Clinical Periodontology 33, 254-264. Silva, M. P., Feres, M., Sirotto, T. A., Soares, G. M., Mendes, J. A., Faveri, M. & Figueiredo, L. C. (2011) Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo-controlled clinical trial. Journal of Clinical Periodontology, 38, 828-837. Lang, N. P. & Tonetti, M. S. (2003) Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT). Oral Health & Preventive Dentistry 1, 7-16. Matuliene, G., Studer, R., Lang, N. P., Schmidlin, K., Pjetursson, B. E., Salvi, G. E., Brägger, U. & Zwahlen, M. (2010) Significance of periodontal risk assessment in the recurrence of periodontitis and tooth loss. Journal of Clinical Periodontology 37, 191-199. Matuliene, G., Pjetursson, B. E., Salvi, G. E., Schmidlin, K., Bragger, U., Zwahlen, M. & Lang, N. P. (2008) Influence of residual pockets on progression of periodontitis and tooth loss: results after 11 years of maintenance. Journal of Clinical Periodontology 35, 685-695. Haffajee, A. D., Socransky, S. S. & Gunsolley, J. C. (2003a) Systemic anti-infective periodontal therapy. A systematic review. The American Academy of Periodontology 8, 115-181. Matarazzo, F., Figueiredo, L. C., Cruz, S. E., Faveri, M. & Feres, M. (2008) Clinical and microbiological benefits of systemic metronidazole and amoxicillin in the treatment of smokers with chronic periodontitis: a randomized placebo-controlled study. Journal of Clinical Periodontology 35, 885-896. Sampaio, E., Rocha, M., Figueiredo, L. C., Faveri, M., Duarte, P. M., Gomes Lira, E. A. & Feres, M. (2011) Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo-controlled clinical trial. Journal of Clinical Periodontology 38, 838-846. Winkel, E. G., van Winkelhoff, A. J., Timmerman, M. F., van der Velden, U. & van der Weijden, G. A. (2001) Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo controlled study. Journal of Clinical Periodontology 28, 296-305. van Winkelhoff, A. J., Rodenburg, J. P., Goené, R. J., Abbas, F., Winkel, E. G. & De Graaff, J. (1989) Metronidazole plus amoxicillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis. Journal of Clinical Periodontology 16, 128-131. 2010; 37 2009; 80 2006; 33 2008; 35 1999; 4 2012; 39 2001; 28 2010; 81 2003a; 8 2011; 38 2007; 34 2010; 89 2009; 36 1987; 22 2004; 31 2002; 29 2003b; 53 1984; 55 1991; 62 2005; 53 2005; 76 2003; 5 2005; 32 2003; 1 1989; 16 e_1_2_6_32_1 e_1_2_6_10_1 e_1_2_6_31_1 e_1_2_6_30_1 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_14_1 e_1_2_6_11_1 Lang N. P. (e_1_2_6_16_1) 2003; 1 e_1_2_6_12_1 e_1_2_6_18_1 e_1_2_6_15_1 e_1_2_6_21_1 e_1_2_6_20_1 e_1_2_6_9_1 Loesche W. J. (e_1_2_6_17_1) 2005; 53 e_1_2_6_8_1 e_1_2_6_5_1 e_1_2_6_4_1 e_1_2_6_7_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_24_1 e_1_2_6_3_1 e_1_2_6_23_1 e_1_2_6_2_1 e_1_2_6_22_1 e_1_2_6_29_1 e_1_2_6_28_1 e_1_2_6_27_1 e_1_2_6_26_1 23773466 - J Evid Based Dent Pract. 2013 Jun;13(2):52-4 |
References_xml | – reference: Yek, E. C., Cintan, S., Topcuoglu, N., Kulekci, G., Issever, H. & Kantarci, A. (2010) Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis. Journal of Periodontology 81, 964-974. – reference: Carvalho, L. H., D'Avila, G. B., Leao, A., Haffajee, A. D., Socransky, S. S. & Feres, M. (2004) Scaling and root planing, systemic metronidazole and professional plaque removal in the treatment of chronic periodontitis in a Brazilian population. I. clinical results. Journal of Clinical Periodontology 31, 1070-1076. – reference: Matuliene, G., Pjetursson, B. E., Salvi, G. E., Schmidlin, K., Bragger, U., Zwahlen, M. & Lang, N. P. (2008) Influence of residual pockets on progression of periodontitis and tooth loss: results after 11 years of maintenance. Journal of Clinical Periodontology 35, 685-695. – reference: Goodson, J. M., Haffajee, A. D., Socransky, S. S., Kent, R., Teles, R., Hasturk, H., Bogren, A., Van Dyke, T., Wennstrom, J. & Lindhe, L. (2012) Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites. Journal of Clinical Periodontology 39, 525-536. – reference: Silva, M. P., Feres, M., Sirotto, T. A., Soares, G. M., Mendes, J. A., Faveri, M. & Figueiredo, L. C. (2011) Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo-controlled clinical trial. Journal of Clinical Periodontology, 38, 828-837. – reference: Loesche, W. J., Giordano, J. R., Soehren, S. & Kaciroti, N. (2005) The nonsurgical treatment of patients with periodontal disease: results after 6.4 years. General Dentistry 53, 298-306. – reference: Lang, N. P. & Tonetti, M. S. (2003) Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT). Oral Health & Preventive Dentistry 1, 7-16. – reference: Ehmke, B., Moter, A., Beikler, T., Milian, E. & Flemmig, T.F. (2005) Adjunctive antimicrobial therapy of periodontitis: long term effects on disease progression and oral colonization. Journal of Periodontology 76, 749-759. – reference: Herrera, D., Sanz, M., Jepsen, S., Needleman, I. & Roldan, S. (2002) A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. Journal of Clinical Periodontology 29, 136-159. – reference: Cionca, N., Giannopoulou, C., Ugolotti, G. & Mombelli, A. (2009) Amoxicillin and metronidazole as an adjunct to full-mouth scaling and root planing of chronic periodontitis. Journal of Periodontology 80, 364-371. – reference: Pihlstrom, B. L. & Barnett, M. L. (2010) Design, operation, and interpretation of clinical trials. Journal of Dental Research 89, 759-772. – reference: Matuliene, G., Studer, R., Lang, N. P., Schmidlin, K., Pjetursson, B. E., Salvi, G. E., Brägger, U. & Zwahlen, M. (2010) Significance of periodontal risk assessment in the recurrence of periodontitis and tooth loss. Journal of Clinical Periodontology 37, 191-199. – reference: Feres, M., Gursky, L. C., Faveri, M., Tsuzuki, C.O. & Figueiredo, L. C. (2009) Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. Journal of Clinical Periodontology 36, 857-867. – reference: Matarazzo, F., Figueiredo, L. C., Cruz, S. E., Faveri, M. & Feres, M. (2008) Clinical and microbiological benefits of systemic metronidazole and amoxicillin in the treatment of smokers with chronic periodontitis: a randomized placebo-controlled study. Journal of Clinical Periodontology 35, 885-896. – reference: Mestnik, M. J., Feres, M., Figueiredo, L. C., Duarte, P. M., Lira, E. A. G. & Faveri, M. (2010) Short-term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in clinical parameters of subjects with generalized aggressive periodontitis. Journal of Clinical Periodontology 37, 353-365. – reference: Aimetti, M., Romano, F., Guzzi, N. & Carnevale, G. (2012) Full-mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo-controlled trial. Journal of Clinical Periodontology 39, 284-294. – reference: Armitage, G. C. (1999) Development of a classification system for periodontal disease and conditions. Annals of Periodontology 4, 1-6. – reference: Loesche, W. J., Syed, S. A., Morrison, E. C., Kerry, G. A., Higgins, T. & Stoll, J. (1984) Metronidazole in periodontitis. I. Clinical and bacteriological results after 15 to 30 weeks. Journal of Periodontology 55, 325-335. – reference: Haffajee, A. D., Socransky, S. S. & Gunsolley, J. C. (2003a) Systemic anti-infective periodontal therapy. A systematic review. The American Academy of Periodontology 8, 115-181. – reference: Xajigeorgiou, C., Sakellari, D., Slini, T., Baka, A. & Konstantinidis, A. (2006) Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis. Journal of Clinical Periodontology 33, 254-264. – reference: Loesche, W. J., Schmidt, E., Smith, B. A., Caffessee, R. & Stoll, J. (1987) Metronidazole therapy for periodontitis. Journal of Periodontal Research 22, 224-226. – reference: Guerrero, A., Griffiths, G. S., Nibali, L., Suvan, J., Moles, D. R., Laurell, L. & Tonetti, M. S. (2005) Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial. Journal of Clinical Periodontololgy 32, 1096-1107. – reference: Loesche, W. J., Schmidt, E., Smith, B. A., Morrison, E. C., Caffesse, R. & Hujoel, P. P. (1991) Effects of metronidazole on periodontal treatment needs. Journal of Periodontology 62, 247-257. – reference: Winkel, E. G., van Winkelhoff, A. J., Timmerman, M. F., van der Velden, U. & van der Weijden, G. A. (2001) Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo controlled study. Journal of Clinical Periodontology 28, 296-305. – reference: Feres, M., Haffajee, A. D., Allard, K., Som, S. & Socransky, S. S. (2001) Change in subgingival microbial profiles in adult periodontitis subjects receiving either systemically-administered amoxicillin or metronidazole. Journal of Clinical Periodontology 28, 597-609. – reference: Greenstein, G. (2003) Clinical versus statistical significance as they relate to the efficacy of periodontal therapy. The Journal of the American Dental Association 5, 583-591. – reference: van Winkelhoff, A. J., Rodenburg, J. P., Goené, R. J., Abbas, F., Winkel, E. G. & De Graaff, J. (1989) Metronidazole plus amoxicillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis. Journal of Clinical Periodontology 16, 128-131. – reference: Haffajee, A.D., Arguello, E.I., Ximenez-Fyvie, L.A. & Socransky, S.S. (2003b) Controlling the plaque biofilm. International Dental Journal 53, 191-199. – reference: Sampaio, E., Rocha, M., Figueiredo, L. C., Faveri, M., Duarte, P. M., Gomes Lira, E. A. & Feres, M. (2011) Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo-controlled clinical trial. Journal of Clinical Periodontology 38, 838-846. – reference: Haffajee, A. D., Torresyap, G. & Socransky, S. S. (2007) Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1 year results. Journal of Clinical Periodontololgy 34, 243-253. – reference: Rooney, J., Wade, W. G., Sprague, S. V., Newcombe, R. G. & Addy, M. (2002) Adjunctive effects to non-surgical periodontal therapy of systemic metronidazole and amoxicillin alone and combined. A placebo controlled study. Journal of Clinical Periodontology 29, 342-350. – volume: 37 start-page: 353 year: 2010 end-page: 365 article-title: Short‐term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in clinical parameters of subjects with generalized aggressive periodontitis publication-title: Journal of Clinical Periodontology – volume: 22 start-page: 224 year: 1987 end-page: 226 article-title: Metronidazole therapy for periodontitis publication-title: Journal of Periodontal Research – volume: 39 start-page: 525 year: 2012 end-page: 536 article-title: Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites publication-title: Journal of Clinical Periodontology – volume: 1 start-page: 7 year: 2003 end-page: 16 article-title: Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT) publication-title: Oral Health & Preventive Dentistry – volume: 33 start-page: 254 year: 2006 end-page: 264 article-title: Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis publication-title: Journal of Clinical Periodontology – volume: 34 start-page: 243 year: 2007 end-page: 253 article-title: Clinical changes following four different periodontal therapies for the treatment of chronic periodontitis: 1 year results publication-title: Journal of Clinical Periodontololgy – volume: 38 start-page: 828 year: 2011 end-page: 837 article-title: Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo‐controlled clinical trial publication-title: Journal of Clinical Periodontology – volume: 35 start-page: 685 year: 2008 end-page: 695 article-title: Influence of residual pockets on progression of periodontitis and tooth loss: results after 11 years of maintenance publication-title: Journal of Clinical Periodontology – volume: 5 start-page: 583 year: 2003 end-page: 591 article-title: Clinical versus statistical significance as they relate to the efficacy of periodontal therapy publication-title: The Journal of the American Dental Association – volume: 4 start-page: 1 year: 1999 end-page: 6 article-title: Development of a classification system for periodontal disease and conditions publication-title: Annals of Periodontology – volume: 38 start-page: 838 year: 2011 end-page: 846 article-title: Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo‐controlled clinical trial publication-title: Journal of Clinical Periodontology – volume: 80 start-page: 364 year: 2009 end-page: 371 article-title: Amoxicillin and metronidazole as an adjunct to full‐mouth scaling and root planing of chronic periodontitis publication-title: Journal of Periodontology – volume: 28 start-page: 597 year: 2001 end-page: 609 article-title: Change in subgingival microbial profiles in adult periodontitis subjects receiving either systemically‐administered amoxicillin or metronidazole publication-title: Journal of Clinical Periodontology – volume: 55 start-page: 325 year: 1984 end-page: 335 article-title: Metronidazole in periodontitis. I. Clinical and bacteriological results after 15 to 30 weeks publication-title: Journal of Periodontology – volume: 8 start-page: 115 year: 2003a end-page: 181 article-title: Systemic anti‐infective periodontal therapy. A systematic review publication-title: The American Academy of Periodontology – volume: 62 start-page: 247 year: 1991 end-page: 257 article-title: Effects of metronidazole on periodontal treatment needs publication-title: Journal of Periodontology – volume: 29 start-page: 136 year: 2002 end-page: 159 article-title: A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients publication-title: Journal of Clinical Periodontology – volume: 53 start-page: 298 year: 2005 end-page: 306 article-title: The nonsurgical treatment of patients with periodontal disease: results after 6.4 years publication-title: General Dentistry – volume: 37 start-page: 191 year: 2010 end-page: 199 article-title: Significance of periodontal risk assessment in the recurrence of periodontitis and tooth loss publication-title: Journal of Clinical Periodontology – volume: 89 start-page: 759 year: 2010 end-page: 772 article-title: Design, operation, and interpretation of clinical trials publication-title: Journal of Dental Research – volume: 35 start-page: 885 year: 2008 end-page: 896 article-title: Clinical and microbiological benefits of systemic metronidazole and amoxicillin in the treatment of smokers with chronic periodontitis: a randomized placebo‐controlled study publication-title: Journal of Clinical Periodontology – volume: 81 start-page: 964 year: 2010 end-page: 974 article-title: Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis publication-title: Journal of Periodontology – volume: 39 start-page: 284 year: 2012 end-page: 294 article-title: Full‐mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo‐controlled trial publication-title: Journal of Clinical Periodontology – volume: 36 start-page: 857 year: 2009 end-page: 867 article-title: Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy publication-title: Journal of Clinical Periodontology – volume: 29 start-page: 342 year: 2002 end-page: 350 article-title: Adjunctive effects to non‐surgical periodontal therapy of systemic metronidazole and amoxicillin alone and combined. A placebo controlled study publication-title: Journal of Clinical Periodontology – volume: 76 start-page: 749 year: 2005 end-page: 759 article-title: Adjunctive antimicrobial therapy of periodontitis: long term effects on disease progression and oral colonization publication-title: Journal of Periodontology – volume: 32 start-page: 1096 year: 2005 end-page: 1107 article-title: Adjunctive benefits of systemic amoxicillin and metronidazole in non‐surgical treatment of generalized aggressive periodontitis: a randomized placebo‐controlled clinical trial publication-title: Journal of Clinical Periodontololgy – volume: 31 start-page: 1070 year: 2004 end-page: 1076 article-title: Scaling and root planing, systemic metronidazole and professional plaque removal in the treatment of chronic periodontitis in a Brazilian population. I. clinical results publication-title: Journal of Clinical Periodontology – volume: 16 start-page: 128 year: 1989 end-page: 131 article-title: Metronidazole plus amoxicillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis publication-title: Journal of Clinical Periodontology – volume: 53 start-page: 191 year: 2003b end-page: 199 article-title: Controlling the plaque biofilm publication-title: International Dental Journal – volume: 28 start-page: 296 year: 2001 end-page: 305 article-title: Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double‐blind placebo controlled study publication-title: Journal of Clinical Periodontology – ident: e_1_2_6_21_1 doi: 10.1111/j.1600-051X.2008.01304.x – ident: e_1_2_6_18_1 doi: 10.1111/j.1600-0765.1987.tb01574.x – ident: e_1_2_6_19_1 doi: 10.1902/jop.1991.62.4.247 – ident: e_1_2_6_20_1 doi: 10.1902/jop.1984.55.6.325 – ident: e_1_2_6_25_1 doi: 10.1177/0022034510374737 – ident: e_1_2_6_12_1 doi: 10.1902/annals.2003.8.1.115 – ident: e_1_2_6_4_1 doi: 10.1111/j.1600-051X.2004.00605.x – ident: e_1_2_6_8_1 doi: 10.1034/j.1600-051x.2001.028007597.x – ident: e_1_2_6_32_1 doi: 10.1902/jop.2010.090522 – volume: 53 start-page: 298 year: 2005 ident: e_1_2_6_17_1 article-title: The nonsurgical treatment of patients with periodontal disease: results after 6.4 years publication-title: General Dentistry – ident: e_1_2_6_31_1 doi: 10.1111/j.1600-051X.2006.00905.x – ident: e_1_2_6_5_1 doi: 10.1902/jop.2009.080540 – ident: e_1_2_6_28_1 doi: 10.1111/j.1600-051X.2011.01763.x – ident: e_1_2_6_22_1 doi: 10.1111/j.1600-051X.2008.01245.x – ident: e_1_2_6_15_1 doi: 10.1034/j.1600-051X.29.s3.8.x – ident: e_1_2_6_13_1 doi: 10.1111/j.1875-595X.2003.tb00770.x – volume: 1 start-page: 7 year: 2003 ident: e_1_2_6_16_1 article-title: Periodontal risk assessment (PRA) for patients in supportive periodontal therapy (SPT) publication-title: Oral Health & Preventive Dentistry – ident: e_1_2_6_10_1 doi: 10.14219/jada.archive.2003.0225 – ident: e_1_2_6_29_1 doi: 10.1034/j.1600-051x.2001.028004296.x – ident: e_1_2_6_2_1 doi: 10.1111/j.1600-051X.2011.01795.x – ident: e_1_2_6_7_1 doi: 10.1111/j.1600-051X.2009.01471.x – ident: e_1_2_6_9_1 doi: 10.1111/j.1600-051X.2012.01870.x – ident: e_1_2_6_11_1 doi: 10.1111/j.1600-051X.2005.00814.x – ident: e_1_2_6_14_1 doi: 10.1111/j.1600-051X.2006.01040.x – ident: e_1_2_6_23_1 doi: 10.1111/j.1600-051X.2009.01508.x – ident: e_1_2_6_3_1 doi: 10.1902/annals.1999.4.1.1 – ident: e_1_2_6_26_1 doi: 10.1034/j.1600-051X.2002.290410.x – ident: e_1_2_6_30_1 doi: 10.1111/j.1600-051X.1989.tb01626.x – ident: e_1_2_6_27_1 doi: 10.1111/j.1600-051X.2011.01766.x – ident: e_1_2_6_6_1 doi: 10.1902/jop.2005.76.5.749 – ident: e_1_2_6_24_1 doi: 10.1111/j.1600-051X.2010.01538.x – reference: 23773466 - J Evid Based Dent Pract. 2013 Jun;13(2):52-4 |
SSID | ssj0017333 |
Score | 2.4043808 |
Snippet | Aim
To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis... View the pubcast on this paper at http://scivee-1.sdsc.edu/node/55261 To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A... Aim To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis... To evaluate the effects of the adjunctive use of metronidazole (MTZ) or MTZ + amoxicillin (AMX) in the treatment of generalized chronic periodontitis (ChP). A... |
SourceID | proquest pubmed pascalfrancis crossref wiley istex |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1149 |
SubjectTerms | Adult amoxicillin Amoxicillin - adverse effects Amoxicillin - therapeutic use Analysis of Variance Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - therapeutic use Antibiotics Antibiotics. Antiinfectious agents. Antiparasitic agents Antifungal agents Antiparasitic agents Biological and medical sciences Chemotherapy, Adjuvant Chlorhexidine - therapeutic use chronic periodontitis Chronic Periodontitis - drug therapy Clinical outcomes Dental Scaling Dentistry Double-Blind Method Drug Combinations Facial bones, jaws, teeth, parodontium: diseases, semeiology Female Humans Logistic Models Longitudinal Studies Male Medical sciences metronidazole Metronidazole - therapeutic use Middle Aged Mouthwashes - therapeutic use Non tumoral diseases Otorhinolaryngology. Stomatology periodontal disease Periodontal Index Periodontal Pocket - drug therapy Periodontal Pocket - pathology periodontal treatment Pharmacology. Drug treatments scaling and root planing Statistics, Nonparametric Treatment Outcome |
Title | Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial |
URI | https://api.istex.fr/ark:/67375/WNG-VLGW280S-N/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fjcpe.12004 https://www.ncbi.nlm.nih.gov/pubmed/23016867 https://www.proquest.com/docview/1433872666 https://www.proquest.com/docview/1171865762 |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFLWqsoAN70egVEYgJBAZTRLbSRAb1KcqOkJAaTco8itSaRpXk0Qqs-IT-Bo-iC_h2k4Cgyok2GUy16Nc577sOT4XoSeplnEmKAtVrnRIlMhDrjgLZRlZPilImMqeRt6fsd0DsndEj1bQq-EsjOeHGDfcrGe4eG0dnIvmdyeXZ3oSxZ4MNEqYJc7ffDdyR0Vp4vvIQ4wOWZ7mPTepg_GMQ5ey0SU7secWHckbmKDSd7a4qPRcrmRdKtq-hj4NSngEysmka8VELv7gd_xfLa-jq32Nil97o7qBVnR9E13etLgi2xruFvq-r13rHMUXptKYV6bW2Myx3dTF_NScH0u7jVNj3mCuPkPqbBvcGlyb-sfXb003d-EWjyB3bEosPUsvtszLsFR2VK_NS8xxBEO-gD9iZTpRafgkKsvxqF5gBygTBm71iPvK3oUJVeb0eKEVHs59Ytec5DY62N76sLEb9g0gQklyQsJyyjVRsZKKsCkBc4unsaQsKUXOCZdJqaTMeCqVpHCdC6U5zYWmliSfEk2SO2gVNNP3EE5SDVJCC6oiUgqSJYrRqMwJLOko4VGAng2GUMieHd026aiKcZUEb6JwbyJAj0fZM88JcqHUU2dPowifn1gUXUqLw9lO8fHNzmGcTd8XswCtLxncOABqpxSeLwvQ2mCBRR9hGliyJUmWgggL0KPxa4gN9g8fXmvTNZbIPQL1IN8F6K633F8_DpGdZSwN0HNnf3_RpNjbeLvlru7_i_ADdAWqy9hjf9bQajvv9EOo4Fqx7jz1J3kbSpU |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtNAFB2hdlE2UN6mpQwCIYFwFNszfrBDfYWSRAha2p01L0ulrqeKE6lkxSfwNXwQX8K9Y8cQVCHBznHuRJ7xfU7OnEvIs8SoMJU89nWmjc-0zHyhReyrIkA-KQiYGk8jj8bx4IgdnPCTFpuDZ2Eafohuww0tw_lrNHDckP7dytWF6QWhYwNdZZBpYO2186FjjwqSqOkkD17aj7Mka9lJHZCnG7sUj1ZxaS8RHylqWKKi6W1xVfK5nMu6YLR3s-m4WjsOQ8SgnPVmU9lT8z8YHv97nuvkRpum0jeNXt0i10x1m6ztILQIu8PdId9HxnXP0WJuS0NFaStD7YTivi4V5_byVOFOTkVFTYX-DNFzWtOppZWtfnz9Vs8mzuPSDudObUFVQ9RLkXwZqmXH9lq_poIGMOQLmCTVdiZLA59kiTSP-hV1mDJp4VYLui_xLqyotuenc6Pp4ugndf1J7pKjvd3D7YHf9oDwFcsY84u-MEyHWmkW9xloXNgPFY-jQmaCCRUVWqlUJEorDteZ1EbwTBqOPPmcGRbdIyswM_OA0CgxICWN5DpghWRppGMeFBmDqo4zEXjkxUITctUSpGOfjjLvCiV4E7l7Ex552sleNLQgV0o9dwrViYjJGQLpEp4fj_fzT8P94zDtf8zHHtla0rhuAKRPCTxf6pHNhQrmrZOpoWqLojQBkdgjT7qvwT3gfz6iMnZWI5d7ANODkOeR-43q_vpxcO5xGiceeekU8C8zyQ-23--6q4f_IvyYrA0OR8N8-Hb8boNch2QzbKBAm2RlOpmZR5DQTeWWM9uf48NOtA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwEB5VrQS8cB-BUoxASCCy2iR2DsQLarstpV1VQI8XFPmKVJrGq82uVPaJn8Cv4QfxSxg72cCiCgneEmccZey57Iy_AXiaaBmmgsW-ypT2qRKZzxWPfVkEFk8KHaayp5H3hvH2Ad05ZsdL8Hp-FqbBh-g23KxmOHttFXykit-VXI50LwgdGOgKjTGUsCHR-w48KkiippA8Gmk_zpKsBSd1eTxd3wV3tGJH9tymR_IaR6hoSltcFHsuhrLOFw2uwac5F00KymlvOhE9OfsD4PF_2bwOV9sglbxppOoGLOnqJlzesIlFtjbcLfi-p13tHMVnptSEl6bSxIyJ3dUl_Mycn0i7j1MRXhOuPqPvnNRkYkhlqh9fv9XTsbO3pMtyJ6YgsoHpJRZ6GdfKDuu1fkU4CbDLF1RIosxUlBrvRGlBHtVL4jLKhMGmNuW-tK04oMqcncy0IvODn8RVJ7kNB4PNj-vbflsBwpc0o9Qv-lxTFSqpcIIpylvYDyWLo0JknHIZFUrKlCdSSYbXmVCas0xoZlHyGdU0ugPLyJm-ByRKNFIJLZgKaCFoGqmYBUVGcU3HKA88eD4XhFy28Oi2SkeZd8sknInczYQHTzraUQMKciHVMydPHQkfn9o0uoTlR8Ot_HB36yhM-x_yoQdrCwLXdcDgKcHvSz1YnUtg3pqYGtdsUZQmSBJ78Lh7jMbB_vHhlTbT2iK5B8geOjwP7jaS--vlaNrjNE48eOHk7y-c5Dvr-5vu6v6_ED-CS_sbg3z37fDdA7iCkWbY5AGtwvJkPNUPMZqbiDWntD8B1c1NYw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Metronidazole+alone+or+with+amoxicillin+as+adjuncts+to+non-surgical+treatment+of+chronic+periodontitis%3A+a+1-year+double-blinded%2C+placebo-controlled%2C+randomized+clinical+trial&rft.jtitle=Journal+of+clinical+periodontology&rft.au=FERES%2C+Magda&rft.au=SILVA+SOARES%2C+Geisla+Mary&rft.au=VELLOSO+MENDES%2C+Juliana+Alethusa&rft.au=PAULINO+SILVA%2C+Maike&rft.date=2012-12-01&rft.pub=Blackwell&rft.issn=0303-6979&rft.volume=39&rft.issue=12&rft.spage=1149&rft.epage=1158&rft_id=info:doi/10.1111%2Fjcpe.12004&rft.externalDBID=n%2Fa&rft.externalDocID=26674088 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0303-6979&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0303-6979&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0303-6979&client=summon |